Findlay, John M. http://orcid.org/0000-0001-5786-4086
Dickson, Edward
Fiorani, Cristina
Bradley, Kevin M.
Mukherjee, Somnath
Gillies, Richard S.
Maynard, Nicholas D.
Middleton, Mark R.
Funding for this research was provided by:
NIHR Oxford Biomedical Research Centre (N/A)
Article History
Received: 15 February 2019
Revised: 21 May 2019
Accepted: 7 June 2019
First Online: 5 July 2019
Compliance with ethical standards
:
: The scientific guarantor of this publication is John Findlay.
: The authors of this manuscript declare relationships with the following companies:JMF has a previous unremunerated advisory relationship with Physiomics.MRM has the following roles to disclose:Advisory/Consulting Role (payment to the individual) Amgen, BMS, GSK, Merck, Millennium, Physiomics and Roche. Research Funding (payment to the institution) from Amgen, AZ, BMS, Clovis, Eisai, GSK, Immunocore, Johnson & Johnson, Merck, Millennium, Novartis, Pfizer, Roche and Vertex.
: One of the authors (JMF) has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: • retrospective• diagnostic or prognostic study• performed at one institution